Cargando…

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial

BACKGROUND: We assessed immunogenicity of three-dose and two-dose immunization schedules with a Sabin-strain inactivated poliovirus vaccine (sIPV) produced by one Chinese vaccine manufacturer. METHODS: This was an open label, randomized, controlled trial conducted in 16 vaccination clinics in Shando...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yamin, Xu, Qing, Jeyaseelan, Vishali, Ying, Zhifang, Mach, Ondrej, Sutter, Roland, Wen, Ning, Rodewald, Lance, Li, Changgui, Wang, Jie, Yuan, Hui, Yin, Zundong, Feng, Zijian, Xu, Aiqiang, An, Zhijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315596/ https://www.ncbi.nlm.nih.gov/pubmed/34327346 http://dx.doi.org/10.1016/j.lanwpc.2021.100133

Ejemplares similares

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
por: Hu, Yuemei, et al.
Publicado: (2019)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021
por: Yang, Hong, et al.
Publicado: (2023)

Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV)
por: Li, Zhuofan, et al.
Publicado: (2018)

A Sabin 1 poliovirus-based vaccine vector transfects Vero cells with high efficiency
por: Li, Changgui, et al.
Publicado: (2007)

The Sabin live poliovirus vaccination trials in the USSR, 1959.
por: Horstmann, D. M.
Publicado: (1991)

Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine
por: Shin, Woo-Jin, et al.
Publicado: (2018)

One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh( )
por: Aziz, Asma B, et al.
Publicado: (2022)

Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey
por: Trueba, Gabriel, et al.
Publicado: (2022)

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique
por: de Deus, Nilsa, et al.
Publicado: (2020)

Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China
por: An, Zhijie, et al.
Publicado: (2021)

In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine
por: Abd-Elghaffar, Asmaa A., et al.
Publicado: (2020)

Vaccinate with Confidence and Finish Strong
por: Rodewald, Lance, et al.
Publicado: (2022)

Regulatory Aspects of Sabin Type 2 Withdrawal From Trivalent Oral Poliovirus Vaccine: Process and Lessons Learned
por: Decina, Daniela, et al.
Publicado: (2017)

Immune persistence of an inactivated poliovirus vaccine derived from the Sabin strain: a 10-year follow-up of a phase 3 study
por: Ma, Lei, et al.
Publicado: (2023)

Detection and Initial Response to a Type 2 Vaccine-Derived Poliovirus — Sichuan Province, China, 2019
por: Zhou, Jiushun, et al.
Publicado: (2020)

Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan
por: Saleem, Ali Faisal, et al.
Publicado: (2017)

Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial
por: Zheng, Yan, et al.
Publicado: (2022)

Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine
por: Hotta, Chiemi, et al.
Publicado: (2019)

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
por: Razafindratsimandresy, Richter, et al.
Publicado: (2018)

Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China
por: Tang, Xuewen, et al.
Publicado: (2023)

Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia
por: Bashorun, Adedapo O, et al.
Publicado: (2021)

Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children
por: Wahid, Rahnuma, et al.
Publicado: (2022)

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2020)

Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks()
por: Estivariz, Concepcion F., et al.
Publicado: (2023)

Fractional-dose inactivated poliovirus vaccine, India
por: Haldar, Pradeep, et al.
Publicado: (2019)

Evaluation of antigenic differences between wild and Sabin vaccine strains of poliovirus using the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2019)

Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis
por: Foiadelli, Thomas, et al.
Publicado: (2016)

Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains
por: Cai, Wei, et al.
Publicado: (2020)

The National Immunization Advisory Committee in China: Roles of National Experts in Making Evidence-Based Recommendations for Immunization
por: Ma, Chao, et al.
Publicado: (2019)

Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization
por: Okayasu, Hiromasa, et al.
Publicado: (2017)

“If the world doesn’t share the vaccine, the virus will take on the world”
por: Yin, Zundong, et al.
Publicado: (2021)

Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China
por: Xu, Yuyang, et al.
Publicado: (2022)

A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad
por: Gamougam, Kadidja, et al.
Publicado: (2021)

Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
por: Ma, Chao, et al.
Publicado: (2022)

Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage
por: Korotkova, Ekaterina A., et al.
Publicado: (2020)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in Vietnam
por: Huyen, Dang Thi Thanh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_prjtrodt21l7r14jl7e9j6t14b